BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34073024)

  • 1. Effects of Reducing L-Carnitine Supplementation on Carnitine Kinetics and Cardiac Function in Hemodialysis Patients: A Multicenter, Single-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Sugiyama M; Hazama T; Nakano K; Urae K; Moriyama T; Ariyoshi T; Kurokawa Y; Kodama G; Wada Y; Yano J; Otsubo Y; Iwatani R; Kinoshita Y; Kaida Y; Nasu M; Shibata R; Tashiro K; Fukami K
    Nutrients; 2021 May; 13(6):. PubMed ID: 34073024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hemodialysis session on the dynamics of carnitine ester profile changes in L-carnitine pretreated end-stage renal disease patients.
    Csiky B; Bene J; Wittmann I; Sulyok E; Melegh B
    Int Urol Nephrol; 2013 Jun; 45(3):847-55. PubMed ID: 22684763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia and carnitine supplementation in hemodialyzed patients.
    Kletzmayr J; Mayer G; Legenstein E; Heinz-Peer G; Leitha T; Hörl WH; Kovarik J
    Kidney Int Suppl; 1999 Mar; 69():S93-106. PubMed ID: 10084293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
    Higuchi T; Abe M; Yamazaki T; Okawa E; Ando H; Hotta S; Oikawa O; Kikuchi F; Okada K; Soma M
    Am J Kidney Dis; 2016 Feb; 67(2):260-70. PubMed ID: 26508680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients.
    Bene J; Csiky B; Wittmann I; Sulyok E; Melegh B
    Ren Fail; 2012; 34(5):555-8. PubMed ID: 22417076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L-carnitine supplementation and adipokines in patients with end-stage renal disease on regular hemodialysis.
    Csiky B; Nyul Z; Tóth G; Wittmann I; Melegh B; Rauh M; Rascher W; Sulyok E
    Exp Clin Endocrinol Diabetes; 2010 Nov; 118(10):735-40. PubMed ID: 20658442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Daily dialyses decrease plasma levels of brain natriuretic peptide (BNP), a biomarker of left ventricular dysfunction.
    Odar-Cederlöf I; Bjellerup P; Williams A; Blagg CR; Twardowski Z; Ting G; Kjellstrand CM
    Hemodial Int; 2006 Oct; 10(4):394-8. PubMed ID: 17014518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of L-Carnitine Supplementation in Patients Receiving Hemodialysis or Peritoneal Dialysis.
    Kuwasawa-Iwasaki M; Io H; Muto M; Ichikawa S; Wakabayashi K; Kanda R; Nakata J; Nohara N; Tomino Y; Suzuki Y
    Nutrients; 2020 Nov; 12(11):. PubMed ID: 33139659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of carnitine supplementation on cardiac function in hemodialyzed children.
    Topaloğlu R; Celiker A; Saatçi U; Kilinç K; Bakkaloğlu A; Beşbaş N; Sezaözen ; Tokel K
    Acta Paediatr Jpn; 1998 Feb; 40(1):26-9. PubMed ID: 9583196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients.
    Brass EP; Adler S; Sietsema KE; Hiatt WR; Orlando AM; Amato A;
    Am J Kidney Dis; 2001 May; 37(5):1018-28. PubMed ID: 11325685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
    Suzuki A; Sakai Y; Hashimoto K; Osawa H; Tsuruoka S
    Ren Fail; 2018 Nov; 40(1):196-200. PubMed ID: 29616582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of a single blind, randomized, placebo-controlled clinical trial to study the effect of intravenous L-carnitine supplementation on health-related quality of life in Indian patients on maintenance hemodialysis.
    Rathod R; Baig MS; Khandelwal PN; Kulkarni SG; Gade PR; Siddiqui S
    Indian J Med Sci; 2006 Apr; 60(4):143-53. PubMed ID: 16679630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carnitine replacement in end-stage renal disease and hemodialysis.
    Calvani M; Benatti P; Mancinelli A; D'Iddio S; Giordano V; Koverech A; Amato A; Brass EP
    Ann N Y Acad Sci; 2004 Nov; 1033():52-66. PubMed ID: 15591003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of L-carnitine supplementation on cardiac morbidity in hemodialyzed patients.
    Matsumoto Y; Sato M; Ohashi H; Araki H; Tadokoro M; Osumi Y; Ito H; Morita H; Amano I
    Am J Nephrol; 2000; 20(3):201-7. PubMed ID: 10878401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of monitoring free carnitine levels for L-carnitine supplementation in hemodialysis patients to maintain carnitine sufficiency and nutritional factors.
    Kumagai E; Hosohata K; Furumachi K; Takai S
    Ther Apher Dial; 2021 Oct; 25(5):595-606. PubMed ID: 33470531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of levocarnitine on brachial-ankle pulse wave velocity in hemodialysis patients: a randomized controlled trial.
    Higuchi T; Abe M; Yamazaki T; Mizuno M; Okawa E; Ando H; Oikawa O; Okada K; Kikuchi F; Soma M
    Nutrients; 2014 Dec; 6(12):5992-6004. PubMed ID: 25533009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic adaptive changes of the serum carnitine esters during and after L-carnitine supplementation in patients with maintenance haemodialysis.
    Bene J; Csiky B; Komlosi K; Sulyok E; Melegh B
    Scand J Clin Lab Invest; 2011 Jul; 71(4):280-6. PubMed ID: 21366497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Unexpected Effects of L-Carnitine Supplementation on Lipid Metabolism in Hemodialysis Patients.
    Katalinic L; Krtalic B; Jelakovic B; Basic-Jukic N
    Kidney Blood Press Res; 2018; 43(4):1113-1120. PubMed ID: 30016788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma brain natriuretic peptide levels in chronic hemodialysis patients: influence of coronary artery disease.
    Nishikimi T; Futoo Y; Tamano K; Takahashi M; Suzuki T; Minami J; Honda T; Uetake S; Asakawa H; Kobayashi N; Horinaka S; Ishimitsu T; Matsuoka H
    Am J Kidney Dis; 2001 Jun; 37(6):1201-8. PubMed ID: 11382689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.